Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. China
  4. Shenzhen Stock Exchange
  5. Shenzhen Salubris Pharmaceuticals Co., Ltd.
  6. Financials
    002294   CNE100000FW8

SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD.

(002294)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization1 21 85120 85829 13830 100--
Entreprise Value (EV)1 21 46320 08928 67329 47329 24629 367
P/E ratio 15,0x29,3x472x41,2x37,0x28,6x
Yield 3,83%2,51%-0,98%1,17%1,46%
Capitalization / Revenue 4,70x4,67x10,6x10,7x9,02x7,79x
EV / Revenue 4,61x4,49x10,5x10,5x8,76x7,60x
EV / EBITDA 11,3x18,4x83,6x30,0x26,5x22,0x
Price to Book 3,28x3,21x5,38x4,75x4,35x3,92x
Nbr of stocks (in thousands) 1 046 0161 046 0161 028 5131 114 817--
Reference price (CNY) 20,919,928,327,027,027,0
Announcement Date 02/27/201902/28/202003/29/2021---
1 CNY in Million
Estimates
Income Statement Evolution (Annual data)
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales1 4 6524 4702 7392 8013 3383 862
EBITDA1 1 9011 0933439831 1061 333
Operating profit (EBIT)1 1 72084679,27148651 113
Operating Margin 37,0%18,9%2,89%25,5%25,9%28,8%
Pre-Tax Profit (EBT)1 1 70685156,79339411 232
Net income1 1 45871560,9684766986
Net margin 31,3%16,0%2,22%24,4%22,9%25,5%
EPS2 1,390,680,060,660,730,94
Dividend per Share2 0,800,50-0,270,320,40
Announcement Date 02/27/201902/28/202003/29/2021---
1 CNY in Million
2 CNY
Income Statement Evolution (Quarterly data)
Fiscal Period: December 2019 Q1 2019 Q2 2019 Q3
Net sales1 1 1891 1681 208
EBITDA ---
Operating profit (EBIT)1 391343113
Operating Margin 32,9%29,4%9,33%
Pre-Tax Profit (EBT)1 385362106
Net income1 32231184,4
Net margin 27,1%26,6%6,98%
EPS2 0,310,290,09
Dividend per Share ---
Announcement Date 04/22/201908/26/201910/28/2019
1 CNY in Million
2 CNY
Balance Sheet Analysis
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt1 ------
Net Cash position1 388769465627854733
Leverage (Debt / EBITDA) -0,20x-0,70x-1,35x-0,64x-0,77x-0,55x
Free Cash Flow 1 009-733---
ROE (Net Profit / Equities) 23,4%11,1%1,03%12,0%12,1%14,1%
Shareholders' equity1 6 2246 4615 9095 7156 3296 993
ROA (Net Profit / Asset) 19,7%9,15%0,83%6,70%7,90%9,50%
Assets1 7 3857 8197 32410 2099 69110 382
Book Value Per Share2 6,376,205,275,696,216,89
Cash Flow per Share2 1,281,441,311,150,650,85
Capex 332-642---
Capex / Sales 7,14%-23,4%---
Announcement Date 02/27/201902/28/202003/29/2021---
1 CNY in Million
2 CNY
Key data
Capitalization (CNY) 30 100 046 445
Capitalization (USD) 4 713 516 724
Net sales (CNY) 2 738 562 300
Net sales (USD) 429 146 405
Number of employees 3 448
Sales / Employee (CNY) 794 247
Sales / Employee (USD) 124 462
Free-Float 35,3%
Free-Float capitalization (CNY) 10 615 565 727
Free-Float capitalization (USD) 1 662 344 498
Avg. Exchange 20 sessions (CNY) 68 691 483
Avg. Exchange 20 sessions (USD) 10 764 299
Average Daily Capital Traded 0,23%
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA